These data confirmed that HO-1 is a downstream target of NRF2 and confirmed the usefulness of db/dbNrf2 KO mice as a preclinical model to study the role of NRF2 in T2D. This evidence concerns the gene NFE2L2 and type 2 diabetes mellitus.